Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1462 | 72 | 0.4407 | 0.5486 | 0.0492 | 0.0710 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3308 | 163 | 0.6325 | 0.5541 | 0.0493 | 0.0507 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1401 | 69 | 1.0202 | 1.0000 | 0.0493 | 0.0520 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2941 | 145 | 0.8865 | 0.7710 | 0.0493 | 0.0544 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 3001 | 148 | 0.2018 | 0.1959 | 0.0493 | 0.0416 |
WM-115 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 1 | 3099 | 153 | 0.8451 | 0.9015 | 0.0494 | 0.0495 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 2 | 16317 | 808 | 0.9755 | 1.0000 | 0.0495 | 0.0476 |
WM-115 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 1 | 2039 | 101 | 0.5557 | 0.4993 | 0.0495 | 0.0637 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 1351 | 67 | 0.9834 | 1.0000 | 0.0496 | 0.0520 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 1917 | 95 | 0.5943 | 0.7294 | 0.0496 | 0.0484 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
WM-115 | Vemurafenib | I-BET151 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3303 | 164 | 0.8997 | 0.9074 | 0.0497 | 0.0514 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2768 | 138 | 0.7587 | 0.6073 | 0.0499 | 0.0523 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 2 | 18224 | 910 | 0.9418 | 0.8926 | 0.0499 | 0.0523 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 2938 | 147 | 0.1338 | 0.1394 | 0.0500 | 0.0554 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2119 | 106 | 1.2403 | 1.1047 | 0.0500 | 0.0462 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1040 | 52 | 0.7567 | 0.7202 | 0.0500 | 0.0513 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2852 | 143 | 0.7815 | 0.9528 | 0.0501 | 0.0436 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 2113 | 106 | 0.5790 | 0.4111 | 0.0502 | 0.0604 |
MZ7-mel | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3728 | 187 | 0.7781 | 0.7316 | 0.0502 | 0.0510 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 3 | 1432 | 72 | 1.3770 | 1.2926 | 0.0503 | 0.0509 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 915 | 46 | 0.6656 | 0.7554 | 0.0503 | 0.0454 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9957 | 502 | 0.4950 | 0.4801 | 0.0504 | 0.0412 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 3036 | 153 | 0.9141 | 0.8443 | 0.0504 | 0.0545 |